Lates News
Artificial intelligence drug developer Absci has announced a partnership with Oracle and AMD to accelerate the generative artificial intelligence-driven drug discovery process. The company's drug discovery platform will leverage Oracle's artificial intelligence infrastructure and AMD's latest hardware.
Latest